When Wang Jun, co-founder of BGI, left the Chinese genomics group to establish a new Shenzhen medical technology company called iCarbonX in 2015, several big venture capitalists of China courted him, hoping that he would take their money. Neil Shen of Sequoia Capital China, who had backed Mr Wang at BGI, thought he would have an inside track. Zhang Lei of Hillhouse Capital offered to write a cheque for as much as Mr Wang wanted. But eventually Mr Wang turned to Tencent founder Ma Huateng, who gave him almost $200m, valuing his young start-up at $1bn.
2015年，華大基因(BGI)聯合創辦人王俊離開這家中國基因組研究集團，在深圳新創辦了一家名爲碳雲智慧(iCarbonX)的醫療科技公司。當時，中國有多個大創投資本家向他伸出了橄欖枝，希望他接受其投資。紅杉中國(Sequoia Capital China)的沈南鵬(Neil Shen)認爲自己會有優勢，因爲紅杉中國曾向在華大基因的王俊提供過資金。而高瓴資本(Hillhouse Capital)的張磊則提出開一張支票，讓王俊想填多少就填多少。不過，王俊最終還是選擇了騰訊(Tencent)創辦人馬化騰，後者向他提供了近2億美元，令他年輕的新創公司的估值達到10億美元。